Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis

Abstract Background Studies on the epidemiological information and prognosis of primary malignant lacrimal gland tumors (MLGTs) are rare for its low occurrence. The goal of our research was to investigate the epidemiological characteristics and survival outcomes of patients with MLGTs. Methods Incid...

Full description

Bibliographic Details
Main Authors: Lin‐feng He, Jin‐di Zhang, Teng‐fei Zhu, Peng‐cheng Zhao, Pei Mou, Shi‐yi Tang
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6831
_version_ 1797216967884537856
author Lin‐feng He
Jin‐di Zhang
Teng‐fei Zhu
Peng‐cheng Zhao
Pei Mou
Shi‐yi Tang
author_facet Lin‐feng He
Jin‐di Zhang
Teng‐fei Zhu
Peng‐cheng Zhao
Pei Mou
Shi‐yi Tang
author_sort Lin‐feng He
collection DOAJ
description Abstract Background Studies on the epidemiological information and prognosis of primary malignant lacrimal gland tumors (MLGTs) are rare for its low occurrence. The goal of our research was to investigate the epidemiological characteristics and survival outcomes of patients with MLGTs. Methods Incidence and demographic information of patients with MLGTs were collected from the Surveillance, Epidemiology, and End Results (SEER) database. To identify independent prognostic factors for disease‐specific survival (DSS) and overall survival (OS), univariate and multivariate Cox regression analysis were performed. Results The overall incidence of primary MLGTs from 1975 to 2020 was 0.413/1,000,000 (according to the 2000 American standard population), with a steadily increasing incidence over years. A total of 964 patients with primary MLGTs were diagnosed, with an average age of 59.3 years. Of these, 53.2% were aged ≥60 years, 57.4% were female, and 77.1% were whites. Multivariate Cox regression analysis demonstrated that year of diagnosis, age, sex, histological type, SEER stage, surgery, and chemotherapy were independent prognostic factors of DSS or OS. Conclusions Although primary MLGT is rare, its incidence has steadily increased in the past 46 years, and surgery was related to a better prognosis.
first_indexed 2024-03-07T15:43:31Z
format Article
id doaj.art-5440063fa47c4e0c8463367a23cf6de5
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-24T11:54:23Z
publishDate 2024-02-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-5440063fa47c4e0c8463367a23cf6de52024-04-09T05:45:47ZengWileyCancer Medicine2045-76342024-02-01133n/an/a10.1002/cam4.6831Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysisLin‐feng He0Jin‐di Zhang1Teng‐fei Zhu2Peng‐cheng Zhao3Pei Mou4Shi‐yi Tang5Department of Ophthalmology Changzheng Hospital, Second Affiliated Hospital of Naval Medical University Shanghai ChinaDepartment of Ophthalmology Changzheng Hospital, Second Affiliated Hospital of Naval Medical University Shanghai ChinaDepartment of Anesthesiology Changzheng Hospital, Second Affiliated Hospital of Naval Medical University Shanghai ChinaDepartment of Anesthesiology Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Ophthalmology Changzheng Hospital, Second Affiliated Hospital of Naval Medical University Shanghai ChinaDepartment of Ophthalmology Gongli Hospital of Shanghai Pudong New Area Shanghai ChinaAbstract Background Studies on the epidemiological information and prognosis of primary malignant lacrimal gland tumors (MLGTs) are rare for its low occurrence. The goal of our research was to investigate the epidemiological characteristics and survival outcomes of patients with MLGTs. Methods Incidence and demographic information of patients with MLGTs were collected from the Surveillance, Epidemiology, and End Results (SEER) database. To identify independent prognostic factors for disease‐specific survival (DSS) and overall survival (OS), univariate and multivariate Cox regression analysis were performed. Results The overall incidence of primary MLGTs from 1975 to 2020 was 0.413/1,000,000 (according to the 2000 American standard population), with a steadily increasing incidence over years. A total of 964 patients with primary MLGTs were diagnosed, with an average age of 59.3 years. Of these, 53.2% were aged ≥60 years, 57.4% were female, and 77.1% were whites. Multivariate Cox regression analysis demonstrated that year of diagnosis, age, sex, histological type, SEER stage, surgery, and chemotherapy were independent prognostic factors of DSS or OS. Conclusions Although primary MLGT is rare, its incidence has steadily increased in the past 46 years, and surgery was related to a better prognosis.https://doi.org/10.1002/cam4.6831incidencelacrimal gland tumorsprognosisSEER
spellingShingle Lin‐feng He
Jin‐di Zhang
Teng‐fei Zhu
Peng‐cheng Zhao
Pei Mou
Shi‐yi Tang
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
Cancer Medicine
incidence
lacrimal gland tumors
prognosis
SEER
title Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
title_full Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
title_fullStr Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
title_full_unstemmed Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
title_short Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
title_sort incidence clinical features and survival outcomes of primary malignant lacrimal gland tumors a population based analysis
topic incidence
lacrimal gland tumors
prognosis
SEER
url https://doi.org/10.1002/cam4.6831
work_keys_str_mv AT linfenghe incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis
AT jindizhang incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis
AT tengfeizhu incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis
AT pengchengzhao incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis
AT peimou incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis
AT shiyitang incidenceclinicalfeaturesandsurvivaloutcomesofprimarymalignantlacrimalglandtumorsapopulationbasedanalysis